capital markets day
play

Capital Markets Day 14 February, 2013 Andrew Williams Chief - PowerPoint PPT Presentation

Capital Markets Day 14 February, 2013 Andrew Williams Chief Executive Kevin Thompson Finance Director Adam Meyers Director Strategic model Active portfolio Long-term market drivers management Financial model Niche products


  1. Capital Markets Day 14 February, 2013 Andrew Williams – Chief Executive Kevin Thompson – Finance Director Adam Meyers – Director

  2. Strategic model Active portfolio Long-term market drivers management Financial model Niche products & strong Organisational agility market positions Halma Capital Markets Day – February 2013

  3. Sustained growth 140 600 Revenue Profit* £m £m 120 500 100 400 80 300 60 200 40 100 20 0 0 72/73 75/76 78/79 81/82 84/85 87/88 90/91 93/4 96/7 99/0 02/3 05/6 08/9 11/12 72/3 75/6 78/9 81/2 84/5 87/8 90/1 93/4 96/7 99/0 02/3 05/06 08/09 11/12 * Before tax, amortisation of intangibles, acquisition costs, movement on contingent consideration and profit on disposal of operations Halma Capital Markets Day – February 2013

  4. % High returns 10 15 20 25 0 5 72/3 75/6 Halma Capital Markets Day – February 2013 78/9 81/2 Return on sales 84/5 87/8 90/1 93/4 96/7 99/0 02/3 05/6 08/9 11/2 pence 10 0 2 4 6 8 72/3 75/6 Dividend per share* 78/9 81/2 * Adjusted for scrip issues 84/5 87/8 90/1 93/4 96/7 99/0 02/3 05/6 08/9 11/2

  5. Growth 2005 - 2012 area proportional to profit 26 24 22 20 18 ROS % 16 14 12 10 0 100 200 300 400 500 600 Revenue £m Halma Capital Markets Day – February 2013

  6. Sector growth 2005 - 2012 area proportional to profit Industrial Safety Health & Analysis Infrastructure Sensors 26 24 22 20 18 ROS % 16 14 12 10 0 50 100 150 200 250 300 Revenue £m Halma Capital Markets Day – February 2013

  7. Reporting Sector changes Industrial Safety Process Safety Infrastructure Sensors Infrastructure Safety Medical Health & Analysis Environmental & Analysis Halma Capital Markets Day – February 2013

  8. New sectors: primary growth drivers Health & Healthcare Life-critical Safety resources Process Safety Infrastructure Safety Medical Environmental & Analysis Halma Capital Markets Day – February 2013

  9. New sectors revenue and profit HY 2012/13 Revenue Profit* £298m £65m Process Safety Infrastructure Safety Medical Environmental & Analysis * Adjusted profit before finance expense and central costs Halma Capital Markets Day – February 2013

  10. Revenue trends Full year revenue Safety Health & Environmental £m £m 200 200 150 150 100 100 50 50 0 0 Mar Mar Mar Mar Mar Mar Mar Mar 2009 2010 2011 2012 2009 2010 2011 2012 Process Safety Infrastructure Safety Medical Environmental & Analysis Halma Capital Markets Day – February 2013

  11. New sectors: revenue by end-market HY 2012/13 gross revenue Process Infrastructure SAFETY Buildings - new £102m £62m Buildings - existing Utilities Healthcare/Medical Scientific/Environmental Medical Environmental Process Industries ENVIRONMENT Energy & Resources HEALTH & Others £60m £79m Halma Capital Markets Day – February 2013

  12. New sectors: revenue by region HY 2012/13 external revenue Process Infrastructure SAFETY £62m £101m UK EUR USA RoW Medical Environmental ENVIRONMENT HEALTH & £60m £75m Halma Capital Markets Day – February 2013

  13. Acquisition pipeline: sectors Infrastructure Process ~500 Medical Environmental Halma Capital Markets Day – February 2013

  14. Acquisition pipeline: sectors and regions Infrastructure Process RoW RoW UK UK US US EUR EUR ~500 UK RoW RoW UK US US EUR EUR Medical Environmental Halma Capital Markets Day – February 2013

  15. Summary � Proven strategy and financial model � New sectors � Reflects sector growth trends � Aligned with growth drivers � Aligned with end-markets � Simplifies reporting � Simplifies investor proposition Halma Capital Markets Day – February 2013

  16. Active portfolio management ‘deep dive’ � M&A model � M&A track record & sustainability � Case study: Health Optics division � Q&A Halma Capital Markets Day – February 2013

  17. M&A model: disciplined decision-making • Halma growth drivers • Strong financial performance BUY SELL • Technology we understand [15-20 year view] [5 year view] • Markets we know • Ambitious local management MERGE Halma Capital Markets Day – February 2013

  18. M&A model: primary focus is growth � Investment for growth � innovation, collaboration & market intelligence � management development � international expansion � mitigate risk � Operational improvement � financial control and intelligence � lean operations Halma Capital Markets Day – February 2013

  19. M&A model: DCEs drive the process Resources HALMA EXTERNAL Typical Timeline DCE* GAE** MDs Finance Broker Advisors Process Search 6 mths – 3 yrs Cultivate Agreement 2 - 3 mths Due diligence Completion 3 - 6 mths Integration Future Accountability * Divisional Chief Executive ** Group Acquisition Executive Halma Capital Markets Day – February 2013

  20. Summary of M&A activity since 2002/03 180 160 140 141 120 (proceeds) / Spend £m 100 105 80 60 50 40 40 20 35 31 24 21 4 14 0 (15) (2) (5) (5) (22) (20) (40) Year end 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 To date No.Acq’ns 2 - 2 3 4 1 2 1 7 2 5 No.Disp’ls - - 8 - 1 - - - 1 1 3 Halma Capital Markets Day – February 2013

  21. Revenue and profit* 2003 – 2012 Subsidiaries in Group at March 2012 before finance expense and central costs Revenue Profit* 700 140 £m £m 120 600 100 500 80 400 60 300 40 200 20 100 0 0 Core Companies Acquired Companies * Excludes operations disposed of between 2003 and 2012 Halma Capital Markets Day – February 2013

  22. Revenue progression* 2003 – 2012 Subsidiaries in Group at March 2012 Total CAGR 11% £m 600 88 576 500 162 Core Organic 400 CAGR 6% 300 133 50 200 35 31 193 100 0 2003 CORE Acquired Acquired 2012 CORE Organic Companies Companies TOTAL Growth Growth * Excludes operations disposed of between 2003 and 2012 Halma Capital Markets Day – February 2013

  23. Profit progression* 2003 – 2012 Subsidiaries in Group at March 2012 before finance expense and central costs £m Total CAGR 13% 150 20 126 36 Core Organic 100 CAGR 7% 33 50 50 37 0 2003 CORE Acquired Acquired 2012 CORE Organic Companies Companies TOTAL Growth Growth * Excludes operations disposed of between 2003 and 2012 Halma Capital Markets Day – February 2013

  24. Optimal rate of growth has 3 key factors Organic growth SHAREHOLDER RETURN M&A Dividend multiples growth Halma Capital Markets Day – February 2013

  25. Acquisition spend for 15% pa total growth* £m 200 180 160 140 Annual spend 120 100 80 60 40 20 0 2013 2014 2015 2016 2017 Year *assumes average multiple 8xEBIT; 7.5% organic growth; Net Debt <1.25xEBITDA Halma Capital Markets Day – February 2013

  26. Span of control is a critical factor to manage 140 140 £m 120 120 100 100 N o Halma Profit 80 80 Companies 60 60 40 40 20 20 0 0 2003 ‘04 ‘05 ‘06 ‘07 ‘08 ‘09 ‘10 ‘11 2012 Year Halma Capital Markets Day – February 2013

  27. Case Study: Health Optics division Adam Meyers – Director Halma Capital Markets Day – February 2013

  28. Health Optics division: ophthalmic market Refractive surgery Diagnostic Instruments Cataract surgery Pharmaceutical £12Bn Lenses & eye care Halma Capital Markets Day – February 2013

  29. Health Optics division: market characteristics � Excellent long term drivers – Healthcare demand � Aging global demographics � Improving worldwide access � Increasingly difficult global regulations � Well-established competitors � Physician choice devices Halma Capital Markets Day – February 2013

  30. Health Optics Health Optics division: what we make Ophthalmology surgical Ophthalmology Primary care diagnostics diagnostics Halma Capital Markets Day – February 2013

  31. Health Optics division: evolution £150m M ICRO S URGICAL TECHNOLOGY ™ Revenue Pre-2005 2007 2009 2011 2013 Halma Capital Markets Day – February 2013

  32. MicroSurgical Technology Inc. � Ophthalmic surgical products, focusing on single-use devices in cataract surgery � $57M at closing with up to $43M contingent consideration � “Typical” M&A process Halma Capital Markets Day – February 2013

  33. MicroSurgical Technology Inc.: next steps � Execute Integration Plan � RoW coverage � Collaborate with Medicel � Explore Divisional synergies � Regulatory � US surgical sales � Capital investment Halma Capital Markets Day – February 2013

  34. Health Optics division – strong global presence Principal operations Sales & support offices Halma Capital Markets Day – February 2013

  35. Health Optics division: expanding opportunities Ophthalmology Primary Care Diagnostic Surgical OEM Physician OEM MICROSURGICAL TECHNOLOGY ™ Core market Secondary market Halma Capital Markets Day – February 2013

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend